214 related articles for article (PubMed ID: 32849921)
21. Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy.
Tang L; Mei Y; Shen Y; He S; Xiao Q; Yin Y; Xu Y; Shao J; Wang W; Cai Z
Int J Nanomedicine; 2021; 16():5811-5829. PubMed ID: 34471353
[TBL] [Abstract][Full Text] [Related]
22. Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance.
De P; Aske J; Sulaiman R; Dey N
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326670
[TBL] [Abstract][Full Text] [Related]
23. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.
Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F
Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321
[TBL] [Abstract][Full Text] [Related]
24. Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts.
Lee PJ; Ho CC; Ho H; Chen WJ; Lin CH; Lai YH; Juan YC; Chu WC; Lee JH; Su SF; Chen HY; Chen JJW; Chang GC; Li KC; Yang PC; Chen HW
Theranostics; 2021; 11(19):9667-9686. PubMed ID: 34646392
[TBL] [Abstract][Full Text] [Related]
25. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
[TBL] [Abstract][Full Text] [Related]
26. Modulation of cancer-associated fibroblasts by nanodelivery system to enhance efficacy of tumor therapy.
Ai W; Liu T; Lv C; Feng X; Wang Q
Nanomedicine (Lond); 2023 Jun; 18(15):1025-1039. PubMed ID: 37584613
[TBL] [Abstract][Full Text] [Related]
27. Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer.
Zheng S; Wang J; Ding N; Chen W; Chen H; Xue M; Chen F; Ni J; Wang Z; Lin Z; Jiang H; Liu X; Wang L
J Nanobiotechnology; 2021 Nov; 19(1):381. PubMed ID: 34802453
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic heterogeneity, stability and plasticity in tumor-promoting carcinoma-associated fibroblasts.
Mezawa Y; Orimo A
FEBS J; 2022 May; 289(9):2429-2447. PubMed ID: 33786982
[TBL] [Abstract][Full Text] [Related]
29. Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer.
Zheng S; Zou Y; Tang Y; Yang A; Liang JY; Wu L; Tian W; Xiao W; Xie X; Yang L; Xie J; Wei W; Xie X
Oncoimmunology; 2022; 11(1):2020984. PubMed ID: 35003899
[TBL] [Abstract][Full Text] [Related]
30. CD36
Jabbari K; Cheng Q; Winkelmaier G; Furuta S; Parvin B
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361532
[TBL] [Abstract][Full Text] [Related]
31. Peptide modified gold nanoparticles for improved cellular uptake, nuclear transport, and intracellular retention.
Yang C; Uertz J; Yohan D; Chithrani BD
Nanoscale; 2014 Oct; 6(20):12026-33. PubMed ID: 25182693
[TBL] [Abstract][Full Text] [Related]
32. Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin.
Ries A; Flehberger D; Slany A; Pirker C; Mader JC; Mohr T; Schelch K; Sinn K; Mosleh B; Hoda MA; Dome B; Dolznig H; Krupitza G; Müllauer L; Gerner C; Berger W; Grusch M
J Exp Clin Cancer Res; 2023 Jan; 42(1):27. PubMed ID: 36683050
[TBL] [Abstract][Full Text] [Related]
33. Polymer coated gold-ferric oxide superparamagnetic nanoparticles for theranostic applications.
Abedin MR; Umapathi S; Mahendrakar H; Laemthong T; Coleman H; Muchangi D; Santra S; Nath M; Barua S
J Nanobiotechnology; 2018 Oct; 16(1):80. PubMed ID: 30316298
[TBL] [Abstract][Full Text] [Related]
34. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.
Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T
Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876
[TBL] [Abstract][Full Text] [Related]
35. Carcinoma associated fibroblasts (CAFs) promote breast cancer motility by suppressing mammalian Diaphanous-related formin-2 (mDia2).
Dvorak KM; Pettee KM; Rubinic-Minotti K; Su R; Nestor-Kalinoski A; Eisenmann KM
PLoS One; 2018; 13(3):e0195278. PubMed ID: 29596520
[TBL] [Abstract][Full Text] [Related]
36. Elucidating the Uptake and Distribution of Nanoparticles in Solid Tumors via a Multilayered Cell Culture Model.
Yohan D; Cruje C; Lu X; Chithrani D
Nanomicro Lett; 2015; 7(2):127-137. PubMed ID: 30464963
[TBL] [Abstract][Full Text] [Related]
37. The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts.
Ansems M; Span PN
Clin Transl Radiat Oncol; 2020 May; 22():90-97. PubMed ID: 32337377
[TBL] [Abstract][Full Text] [Related]
38. Serum Proteins Enhance Dispersion Stability and Influence the Cytotoxicity and Dosimetry of ZnO Nanoparticles in Suspension and Adherent Cancer Cell Models.
Anders CB; Chess JJ; Wingett DG; Punnoose A
Nanoscale Res Lett; 2015 Dec; 10(1):448. PubMed ID: 26577392
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
González L; Eiro N; Fernandez-Garcia B; González LO; Dominguez F; Vizoso FJ
Mol Carcinog; 2016 Nov; 55(11):1489-1502. PubMed ID: 26349857
[TBL] [Abstract][Full Text] [Related]
40. The case for cancer-associated fibroblasts: essential elements in cancer drug discovery?
Brewer G; Fortier AM; Park M; Moraes C
Future Drug Discov; 2022 Jan; 4(1):FDD71. PubMed ID: 35600290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
